Articles

The Department of Veterans Affairs has decided to severely limit the use of Avandia, the once-popular drug for Type 2 diabetes, delivering another blow to the product’s maker, GlaxoSmithKline.

The FDA warned healthcare professionals that sudden loss of hearing has been reported in patients taking phosphodiesterase 5 (PDE-5) inhibitors.

Merck & Co. added warnings to its diabetes pill Januvia after some patients developed allergic conditions, including a rare, severe skin disorder.

Aspirin does not prevent heart attack for women to the same extent that it does for men, researchers affirmed.

Twice-daily use of diabetes drug Januvia (sitagliptin) in combination with metformin significantly improved blood sugar control in newly diagnosed type 2 diabetics, according to a new study.

A diet rich in the fatty acids protects against later onset of the disease

Study finds that it does this outside of the normal risk factors for diabetes, such as obesity.

MRSA infections are associated with more than 18,000 U.S. deaths each year.

Long-term therapy with pioglitazone in patients with cardiovascular disease and type 2 diabetes not only reduces risk of death, myocardial infarction, or stroke, but it also has favourable effects on lipid markers in patients on statin therapy

A new prospective cohort study shows that negative aspects of a close relationship–such as not confiding and not getting emotional support–can increase the risk of coronary events for both men and women.